Analysis of the domestic market of medicines used for the symptomatic treatment of cough

Authors

DOI:

https://doi.org/10.24959/sphhcj.21.236

Keywords:

market analysis; medicines, pharmaceutical market of Ukraine; cough treatment; assortment.

Abstract

To study of the range of medicines for the symptomatic treatment of cough at the pharmaceutical market of Ukraine.

References

References

Zaitsev, A. A. (2018). Mucoactive cough therapy: what is behind the horizon? Lechaschi Vrach, 10, 22–27.

Zaitsev, A. A., Okovityi, S. V., Kriukov, E. V. (2015). Kashel. Prakticheskoe posobie dlia vrachei. Moscow: GVKG im. N. N. Burdenko, 59.

Chernykh, V. P., Zupanets, I. A., Kupnovytska, I. H. et al. (Eds.). (2013). Oryhinalni ta henerychni likarski preparaty. Samolikuvannia y farmatsevtychna opika. Klinichna farmatsiia. Kharkiv: NFaU: Zoloti storinky, 911.

Finley, C. R., Chan, D. S., Garrison, S., Korownyk, Ch., Kolber, M. R., Campbell, S., Eurich, D. T. et al. (2018). What are the most common conditions in primary care? Systematic review. Canadian Family Physician, 64 (11), 832–840.

Balbani, А. Р. S. (2012). Cough: neurophysiology, methods of research, pharmacological therapy and phonoaudiology. International archives of otorhinolaryngology, 16 (2), 259–268. doi: https://doi.org/10.7162/S1809-97772012000200016.

MOZ Ukrainy. (2019). Nakaz vid 05.06.2019 No. 1269 “Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry kashli”. moz.gov.ua. Available at: https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-05062019--1269-pro-zatverdzhennja-ta-vprovadzhennja-mediko-tehnologichnih-dokumentiv-zi-standartizacii-ekstrenoi-medichnoi-dopomogi.

MOZ Ukrainy. (2015). Nakaz vid 08.06.2015 No. 327 “Unifikovanyi klinichnyi protokol pervynnoi medychnoi dopomohy. Kashel u doroslykh”. dec.gov.ua. Available at: https://www.dec.gov.ua/wp-content/uploads/2019/11/2015_327ykpmd_kashel_dor.pdf.

Asthma Workgroup, Chinese Society, Respiratory, Diseases (CSRD), Chinese Medical Association. (2011). The Chinese national guidelines on diagnosis and management of cough. Chinese Medical J., 124 (20), 3207–3219. Available at: https://pubmed.ncbi.nlm.nih.gov/22088510/.

Morice, A. (2002). Epidemiology of cough. Pulmonary Pharmacology and Therapeutics, 15 (3), 253–259. doi: https://doi.org/10.1006/pupt.2002.0352.

Khimion, L. V., Yashchenko, O. B., Danyliuk, S. V., Sytiuk, T. O. (2016). Symptomatic treatment of cough in adults. Zdorov’ia Ukrainy 21 storichchia, 1 (374), 3–5. Available at: https://health-ua.com/wp-content/uploads/2016/03/3-5.pdf.

Aptechna Profesiina Asotsiatsiia Ukrainy. (2019). Na dopomohu farmatsevtu: suchasni aspekty likuvannia kashliu u ditei. apau.org.ua. Available at: https://apau.org.ua/2019/02/07/.

Chulovska, U. B. (2021). Zdorov’ia Ukrainy 21 storichchia, 10 (503), 52–54. Available at: https://health-ua.com/article/66171-suchasn-strateg-lkuvannya-kashlyu-vterapevtichnj-praktitc.

Koskela, H. O., Lätti, A. M., Pekkanen, J. (2018). The impacts of cough : a cross-sectional study in a Finnish adult employee population. ERJ Open Research, 12 (4), 00113-2018. doi: 10.1183/23120541.00113-2018.

Derzhavnyi reiestr likarskykh zasobiv Ukrainy. Available at: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument&atscode=R05.

Kovalenko, V. M. (Ed.). (2019). Compendium 2019 – drugs. Kyiv: MORION, 2480.

Onyshkiv, O. I., Lekh, I. P., Hroshovyi, T. A. (2015). Pharmaceutical Journal, 1, 71–75.

Kukhtenko, O. S., Hladukh, E. V., Simonian, L. S. (2017). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4 (52), 42–49. doi: https://doi.org/10.24959/uekj.17.35.

Downloads

Published

2021-12-24

Issue

Vol. 7 No. 4 (2021)

Section

Social marketing and pharmacoeconomic research

License

Copyright (c) 2021 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).